Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids and Organs-on-Chips 2021

MoonSun Jung's Biography



MoonSun Jung, Senior Research Officer, Children’s Cancer Institute Australia

Dr MoonSun Jung is a cancer researcher at the Children’s Cancer Institute (CCI), Australia. She received her PhD in Biomedical Engineering at the UNSW, Sydney where she gained advanced knowledge and experience in biomaterials engineering. She joined the CCI in 2011 and has played a major role in driving research projects in cancer cell biology and clinical data analysis in both childhood and adult cancers. Dr Jung’s research led to the identification of prognostic markers and therapeutic targets in cancers. Dr Jung is currently Senior Research Officer at CCI and leads a research project that aims to develop 3D bio-printed cancer models to predict cancer therapeutic response and understand metastasis in this disease.

MoonSun Jung Image

Bioprinting of 3D Extracellular Matrix Models For Cancer Research

Tuesday, 23 March 2021 at 09:45

Add to Calendar ▼2021-03-23 09:45:002021-03-23 10:45:00Europe/LondonBioprinting of 3D Extracellular Matrix Models For Cancer Research3D-Culture, Organoids and Organs-on-Chips 2021 in BostonBostonSELECTBIOenquiries@selectbiosciences.com

Cancer is a leading cause of mortality and morbidity worldwide. However, the exact molecular mechanisms underlying the tumorigenesis and metastasis are still poorly understood. Conventional 2-dimentional (2D) in vitro models are widely used for cancer research. These monolayer models however cannot accurately recapitulate the characteristics of native tumor microenvironment, including the cell-cell and cell-matrix interactions that cancer cells experience in vivo. 3D bioprinting provides an exciting opportunity to create in vitro tumor microenvironment with living cells using extracellular matrix (ECM) materials. However, it is still rare that 3D bioprinted models use biomaterials with high biocompatibility and tunability of the ECM-like properties. In collaboration with Inventia Life Science, we have developed 3D matrix models by printing small droplets of cells and matrix components using their drop-on-demand 3D bioprinter. With this technology, we are currently investigating the diverse aspects of cancer behaviours in response to environmental changes such as stiffness and biological molecules and identifying optimal biomimic ECM conditions for different cancer types.


Add to Calendar ▼2021-03-22 00:00:002021-03-23 00:00:00Europe/London3D-Culture, Organoids and Organs-on-Chips 20213D-Culture, Organoids and Organs-on-Chips 2021 in BostonBostonSELECTBIOenquiries@selectbiosciences.com